As predicted here, Baxter - the world’s largest peritoneal dialysis operator - has purchased Gambro, the second-largest player in haemodialysis in Europe, for SEK 26.5bn (€3.08bn) from EQT and Investor. The deal is seen as a way for Baxter to present itself as a "one-stop shop" to payors and providers, and to better compete with Fresenius, the world’s largest player in dialysis.